ClinicalTrials.Veeva

Menu

Outcomes of Sepsis Patients in China (CHINA-SEP)

S

Southeast University, China

Status

Not yet enrolling

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT07066553
2025ZDSYLL251-P01

Details and patient eligibility

About

Sepsis poses a significant public health challenge in China. However, longitudinal real-world evidence on guideline adherence and patient outcomes remains scarce. This registry aims to address these gaps by systematically capturing guideline-concordant treatment patterns and associated outcomes in ICU patients diagnosed according to Sepsis-3.0 criteria across diverse settings, thereby generating actionable evidence to improve the quality of sepsis care nationwide.

Full description

Sepsis is a major public health challenge in China and remains one of the leading causes of intensive care unit (ICU) admissions, accounting for approximately 20.6% of all ICU cases. However, longitudinal real-world data on adherence to clinical guidelines and associated patient outcomes remain limited. This multicenter observational registry is designed to systematically capture real-world management data from adult ICU patients diagnosed with sepsis according to Sepsis-3.0 criteria. The study will assess current treatment practices and document infection types, anatomical sites, pathogen profiles, and key clinical outcomes. By examining the relationship between treatment patterns and outcomes, this study aims to generate actionable evidence to improve the quality of sepsis care in China. The findings will help identify practice variability, support updates to national guidelines, and promote standardized, evidence-based management across the country.

Enrollment

5,775 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalized patients aged ≥18 years
  • Sepsis diagnosis meeting Sepsis-3 criteria
  • Informed consent signed by patient or legally authorized representative

Exclusion criteria

  • Patients with a prior history of sepsis
  • Sepsis diagnosis >48 hours prior to enrollment
  • Current participation in clinical trial

Trial design

5,775 participants in 1 patient group

Sepsis Group
Description:
The sepsis group comprised patients diagnosed with sepsis (Sepsis-3 criteria).

Trial contacts and locations

1

Loading...

Central trial contact

Professor Liu Songqiao

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems